Trials / Completed
CompletedNCT02430688
Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms
Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms: Phase I and Phase II Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Fuda Cancer Hospital, Guangzhou · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Extremities Neoplasms.
Detailed description
By enrolling patients with unresectable Extremites Neoplasms adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous IRE for unresectable Extremities Neoplasms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Irreversible electroporation (IRE) | |
| DEVICE | NanoKnife |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2020-12-01
- Completion
- 2021-02-01
- First posted
- 2015-04-30
- Last updated
- 2021-09-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02430688. Inclusion in this directory is not an endorsement.